Accueil › Cancer métastatique › Maryland › Baltimore
Essais cliniques pour Cancer métastatique à Baltimore, MD
28 études pour Cancer métastatique recherchent des participants dans et autour de Baltimore (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Recrutement en coursPhase 2
- University of Maryland/Greenebaum Cancer Center, Baltimore
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Recrutement en coursPhase 3
- Greater Baltimore Medical Center, Baltimore
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Recrutement en coursPhase 2/3
- JHU Oncology Central Kit Services, Baltimore
- Johns Hopkins Hospital, Baltimore
- Oncology Investigational Drug Service (IDS), Baltimore
- et 1 autres
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Maryland Oncology Hematology, P.A., Annapolis · à 22 mi
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Recrutement en coursPhase 1
- John Hopkins University, Baltimore
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Recrutement en coursPhase 3
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital Of Baltimore, Baltimore
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recrutement en coursPhase 3
- Johns Hopkins Hospital, Baltimore
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- Johns Hopkins Bayview Medical Center, Baltimore
NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
Recrutement en coursPhase 1
- Johns Hopkins, Baltimore
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Recrutement en coursPhase 1
- Johns Hopkins Kimmel Cancer Center, Baltimore
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Recrutement en coursPhase 2
- Research Site, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Recrutement en coursPhase 3
- Research Site, Baltimore
- Research Site, Baltimore
REMASTer: REcurrent Brain Metastases After SRS Trial
Recrutement en cours
- University of Maryland, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Recrutement en coursPhase 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · à 9 mi
- United Theranostics - Chesapeake, Glen Burnie · à 9 mi
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Recrutement en coursPhase 1
- Johns Hopkins University, Baltimore
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
Recrutement en coursPhase 1
- University of Maryland, Baltimore
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Recrutement en coursPhase 1/2
- John Hopkins University, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Recrutement en coursPhase 1/2
- Johns Hopkins University, Baltimore
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Recrutement en coursPhase 1/2
- Johns Hopkins University, Baltimore
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Recrutement en coursPhase 3
- University of Maryland, Baltimore
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Recrutement en coursPhase 2/3
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Recrutement en coursPhase 1
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Bayview Medical Center, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Recrutement en coursPhase 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Recrutement en coursPhase 3
- Johns Hopkins University, Baltimore
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Recrutement en coursPhase 1
- Chesapeake Urology, Towson · à 8 mi
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Recrutement en coursPhase 1
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · à 8 mi
Essais pour Cancer métastatique dans d'autres villes
- Houston, TX104 études
- New York City, NY93 études
- Nashville, TN70 études
- Boston, MA63 études
- Los Angeles, CA57 études
- St. Louis, MO54 études
- Arlington, VA53 études
- Philadelphia, PA46 études
- Chicago, IL45 études
- San Antonio, TX44 études
- Washington, DC43 études
- Dallas, TX42 études
Autres études à Baltimore
- Cancer du poumon non à petites cellules60 études
- Cancer du sein47 études
- Cancer de la prostate43 études
- Cancer du poumon40 études
- Cancer (tous types)37 études
- Cancer du pancréas31 études
- Cancer colorectal31 études
- Obésité26 études
- Cancer de la vessie24 études
- Insuffisance cardiaque24 études
- Cancer de l'ovaire22 études
- Accident vasculaire cérébral21 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.